Treatment of trauma-affected refugees with venlafaxine versus sertraline combined with psychotherapy - a randomised study

Charlotte Sonne, Jessica Carlsson, Per Bech, Ask Elklit, Erik Lykke Mortensen, Charlotte Sonne, Jessica Carlsson, Per Bech, Ask Elklit, Erik Lykke Mortensen

Abstract

Background: The prevalence of trauma-related psychiatric disorders is high among refugees. Despite this, little is known about the effect of pharmacological treatment for this patient group. The objective of the present study was therefore to examine differences in the effects of venlafaxine and sertraline on Post-Traumatic Stress Disorder (PTSD), depression and functional impairment in trauma-affected refugees.

Methods: The study was a randomised pragmatic trial comparing venlafaxine and sertraline in combination with psychotherapy and social counselling. PTSD symptoms were measured on the Harvard Trauma Questionnaire - part IV, which was the primary outcome measure. Other outcome measures included: Hopkins Symptom Check List-25 (depression and anxiety), Social Adjustment Scale - short version (social functioning), WHO-5 Well-being Index (quality of life), Crisis Support Scale (support from social network), Sheehan Disability Scale (disability in three areas of functioning), Hamilton Depression and Anxiety scale, the somatisation items of the Symptoms Checklist-90, Global Assessment of Functioning scales and the summarised score of pain in four body areas rated on visual analogue scales.

Results: Two hundred seven adult refugee patients were included in the trial (98 in the venlafaxine and 109 in the sertraline group). Of these, 195 patients were eligible for intention-to-treat analyses. Small but significant pre-treatment to post-treatment differences were found on the Harvard Trauma Questionnaire and a number of other ratings in both groups. On the primary outcome measure, no difference was found in treatment effect between the sertraline and venlafaxine group. A significant group difference was found in favour of sertraline on the Sheehan Disability Scale.

Conclusion: Sertraline had a slightly better outcome than venlafaxine on some of the secondary outcome measures, but not on the primary outcome measure. Furthermore, a higher percentage of dropouts was found in the venlafaxine group compared to the sertraline group. Although this could indicate that sertraline was better tolerated, which is supported by other studies, a final conclusion on tolerability cannot be drawn from the current study due to lack of systematic reporting of side effects.

Trial registration: ClinicalTrials.gov NCT01569685 . Registration date: 28/2/12.

Keywords: Depression; Refugee; Sertraline; Stress disorders, Post-traumatic stress disorders; Trauma; Venlafaxine.

Figures

Fig. 1
Fig. 1
Participants flow through the trial

References

    1. Steel Z, Chey T, Silove D, Marnane C, Bryant RA, van Ommeren M. Association of torture and other potentially traumatic events with mental health outcomes among populations exposed to mass conflict and displacement: a systematic review and meta-analysis. JAMA. 2009;302(5):537–49. doi: 10.1001/jama.2009.1132.
    1. Crumlish N, O’Rourke K. A systematic review of treatments for post-traumatic stress disorder among refugees and asylum-seekers. J Nerv Ment Dis. 2010;198(4):237–51. doi: 10.1097/NMD.0b013e3181d61258.
    1. Sonne C, Carlsson JM, Bech P, Mortensen EL. Pharmacological treatment of trauma-affected refugees. Transcult Psychiatry. In press.
    1. Watts BV, Schnurr PP, Mayo L, Young-Xu Y, Weeks WB, Friedman MJ. Meta-analysis of the efficacy of treatments for posttraumatic stress disorder. J Clin Psychiatry. 2013;74(6):e541–50. doi: 10.4088/JCP.12r08225.
    1. Bisson J, Andrew M. Psychological treatment of post-traumatic stress disorder (PTSD). CCochrane Database Syst Rev. 2007;(3). Art. No.: CD003388. doi:10.1002/14651858.CD003388.pub3.
    1. Hetrick SE, Purcell R, Garner B, Parslow R. Combined pharmacotherapy and psychological therapies for post traumatic stress disorder (PTSD). Cochrane Database Syst Rev. 2010;(7). Art. No.: CD007316. doi:10.1002/14651858.CD007316.pub2.
    1. Stein DJ, Ipser JC, Seedat S. Pharmacotherapy for post traumatic stress disorder (PTSD). Cochrane Database Syst Rev. 2006;(1). Art. No.: CD002795. doi:10.1002/14651858.CD002795.pub2.
    1. Noerregaard C. Culture and biology in psychopharmacological treatment of ethnic minorities. Ugeskr Laeger. 2012;6:337–40.
    1. Hollifield M. Measuring trauma and health status in refugees: a critical review. JAMA J Am Med Assoc. 2002;288(5):611–21. doi: 10.1001/jama.288.5.611.
    1. Kinzie JD. Guidelines for psychiatric care of torture survivors. Torture. 2011;21(1):18–26.
    1. Otto MW, Hinton D, Korbly NB, Chea A, Ba P, Gershuny BS, et al. Treatment of pharmacotherapy-refractory posttraumatic stress disorder among Cambodian refugees: a pilot study of combination treatment with cognitive-behavior therapy vs sertraline alone. Behav Res Ther. 2003;41(11):1271–6. doi: 10.1016/S0005-7967(03)00032-9.
    1. Patel N, Kellezi B, Williams AC de C. Psychological, social and welfare interventions for psychological health and well-being of torture survivors. Cochrane Database Syst Rev. 2014;11:CD009317.
    1. McFarlane CA, Kaplan I. Evidence-based psychological interventions for adult survivors of torture and trauma: a 30-year review. Transcult Psychiatry. 2012;49(3–4):539–67. doi: 10.1177/1363461512447608.
    1. Buhmann CB, Nordentoft M, Ekstroem M, Carlsson J, Mortensen EL. The effect of flexible cognitive-behavioural therapy and medical treatment, including antidepressants on post-traumatic stress disorder and depression in traumatised refugees: pragmatic randomised controlled clinical trial. Br J Psychiatry. 2015;5.
    1. Vindbjerg E, Klimpke C, Carlsson J. Psychotherapy with traumatised refugees--the design of a randomised clinical trial. Torture. 2014;24(1):40–8.
    1. Region Syddanmarks Center for Kvalitet . MTV om behandling og rehabilitering af PTSD – herunder traumatiserede flygtninge. 2008.
    1. Davidson J, Rothbaum BO, Tucker P, Asnis G, Benattia I, Musgnung JJ. Venlafaxine extended release in posttraumatic stress disorder: a sertraline- and placebo-controlled study. J Clin Psychopharmacol. 2006;26(3):259–67. doi: 10.1097/01.jcp.0000222514.71390.c1.
    1. Buhmann CB. Traumatized refugees: morbidity, treatment and predictors of outcome. Dan Med J. 2014;61(8):B4871.
    1. Smajkic A, Weine S, Djuric-Bijedic Z, Boskailo E, Lewis J, Pavkovic I. Sertraline, paroxetine, and venlafaxine in refugee posttraumatic stress disorder with depression symptoms. J Trauma Stress. 2001;14(3):445–52. doi: 10.1023/A:1011177420069.
    1. Sonne C, Carlsson J, Elklit A, Mortensen EL, Ekstrøm M. Treatment of traumatized refugees with sertraline versus venlafaxine in combination with psychotherapy - study protocol for a randomized clinical trial. Trials. 2013;14:137. doi: 10.1186/1745-6215-14-137.
    1. WHO . The ICD-10 Classification of Mental and Behavioural Disorders - Diagnostic criteria for research. 1993.
    1. Braakman MH, Kortmann FAM, van den Brink W. Validity of “post-traumatic stress disorder with secondary psychotic features”: a review of the evidence. Acta Psychiatr Scand. 2009;119(1):15–24. doi: 10.1111/j.1600-0447.2008.01252.x.
    1. Norredam M, Jensen M, Ekstrøm M. Psychotic symptoms in refugees diagnosed with PTSD: a series of case reports. Nord J Psychiatry. 2011;65(4):283–8. doi: 10.3109/08039488.2010.533385.
    1. Carlsson J, Sonne C, Silove D. From pioneers to scientists: challenges in establishing evidence-gathering models in torture and trauma mental health services for refugees. J Nerv Ment Dis. 2014;202(9):630–7. doi: 10.1097/NMD.0000000000000175.
    1. Sonne C, Vindbjerg E. Manualised psychotherapy in a transcultural refugee setting. Psychother Aust. 2013;19(3):55.
    1. Mollica RF, Caspi-Yavin Y, Bollini P, Truong T, Tor S, Lavelle J. The Harvard trauma questionnaire. Validating a cross-cultural instrument for measuring torture, trauma, and posttraumatic stress disorder in Indochinese refugees. J Nerv Ment Dis. 1992;180(2):111–6. doi: 10.1097/00005053-199202000-00008.
    1. Kleijn WC, Hovens JE, Rodenburg JJ. Posttraumatic stress symptoms in refugees: assessments with the Harvard trauma questionnaire and the Hopkins symptom checklist-25 in different languages. Psychol Rep. 2001;88(2):527–32. doi: 10.2466/pr0.2001.88.2.527.
    1. Mollica RF, Wyshak G, de Marneffe D, Khuon F, Lavelle J. Indochinese versions of the Hopkins symptom checklist-25: a screening instrument for the psychiatric care of refugees. Am J Psychiatry. 1987;144(4):497–500. doi: 10.1176/ajp.144.4.497.
    1. Bech P, Kastrup M, Rafaelsen OJ. Mini-compendium of rating scales for states of anxiety depression mania schizophrenia with corresponding DSM-III syndromes. Acta Psychiatr Scand Suppl. 1986;326:1–37.
    1. Weissman MM, Olfson M, Gameroff MJ, Feder A, Fuentes M. A comparison of three scales for assessing social functioning in primary care. Am J Psychiatry. 2001;158(3):460–6. doi: 10.1176/appi.ajp.158.3.460.
    1. Palic S, Elklit A. An explorative outcome study of CBT-based multidisciplinary treatment in a diverse group of refugees from a Danish treatment centre for rehabilitation of traumatized refugees. Torture. 2009;19(3):248–70.
    1. Sheehan DV. The anxiety disease. 1986.
    1. Topp CW, Østergaard SD, Søndergaard S, Bech P. The WHO-5 well-being index: a systematic review of the literature. Psychother Psychosom. 2015;84(3):167–76. doi: 10.1159/000376585.
    1. Bastin P, Bastard M, Rossel L, Melgar P, Jones A, Antierens A. Description and predictive factors of individual outcomes in a refugee camp based mental health intervention (Beirut, Lebanon) PLoS One. 2013;8(1):e54107. doi: 10.1371/journal.pone.0054107.
    1. Hoskins M, Pearce J, Bethell A, Dankova L, Barbui C, Tol WA, et al. Pharmacotherapy for post-traumatic stress disorder: systematic review and meta-analysis. Br J Psychiatry. 2015;206(2):93–100. doi: 10.1192/bjp.bp.114.148551.
    1. Ipser JC, Stein DJ. Evidence-based pharmacotherapy of post-traumatic stress disorder (PTSD) Int J Neuropsychopharmacol. 2012;15(6):825–40. doi: 10.1017/S1461145711001209.
    1. Redrobe JP, Bourin M, Colombel MC, Baker GB. Dose-dependent noradrenergic and serotonergic properties of venlafaxine in animal models indicative of antidepressant activity. Psychopharmacology (Berl) 1998;138(1):1–8. doi: 10.1007/s002130050638.
    1. Cipriani A, Furukawa TA, Salanti G, Geddes JR, Higgins JP, Churchill R, et al. Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. Lancet (London, England) 2009;373(9665):746–58. doi: 10.1016/S0140-6736(09)60046-5.
    1. Sonne C, Carlsson J, Bech P, Vindbjerg E, Mortensen EL, Elklit A. Psychosocial predictors of treatment outcome for trauma-affected refugees. Eur J Psychotraumatol. 2016;7:30907. doi: 10.3402/ejpt.v7.30907.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe